mesalamine has been researched along with Cancer of Skin in 3 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Reolid, A | 1 |
Rodríguez-Jiménez, P | 1 |
Llamas-Velasco, M | 1 |
Chicharro, P | 1 |
Fraga, J | 1 |
Aragüés, M | 1 |
Goldie, SJ | 1 |
Cottle, DL | 1 |
Tan, FH | 1 |
Roslan, S | 1 |
Srivastava, S | 1 |
Brady, R | 1 |
Partridge, DD | 1 |
Auden, A | 1 |
Smyth, IM | 1 |
Jane, SM | 1 |
Dworkin, S | 1 |
Darido, C | 1 |
Peltonen, S | 1 |
Kankuri-Tammilehto, M | 1 |
1 review available for mesalamine and Cancer of Skin
Article | Year |
---|---|
Leukemic Vasculitis: Case Report and Review of the Literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Marrow Transplantation; | 2019 |
2 other studies available for mesalamine and Cancer of Skin
Article | Year |
---|---|
Loss of GRHL3 leads to TARC/CCL17-mediated keratinocyte proliferation in the epidermis.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line; Cell Proliferation; Chemokine CCL17; DNA-Binding Prote | 2018 |
Brooke-Spiegler syndrome associated with ulcerative rectosigmoiditis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Mesalamine; Neoplastic Syndromes, He | 2013 |